Differential Diagnosis of Polyneuropathy

Peripheral Neuropathy

Volumn 1, Issue , 2005, Pages 1163-1180

  Grant, Ian A ^a   Benstead, Timothy J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 43449137032     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50049-1     Document Type: Chapter

References (148)

1. Abarbanel J.M., Berginer V.M., Osimani A., et al. Neurologic complications after gastric restriction surgery for morbid obesity. Neurology 1987, 37:196.
2. Akiya S., Nishio Y., Ibi K., et al. Lattice corneal dystrophy type II associated with familial amyloid polyneuropathy type IV. Ophthalmology 1996, 103:1106.
3. Albers J.W., Kelly J.J. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989, 12:435.
4. Andersson P.B., Yuen E., Parko K., So Y.T. Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. Neurology 2000, 54:40.
5. Archer A.G., Watkins P.J., Thomas P.K., et al. The natural history of acute painful neuropathy in diabetes mellitus. J. Neurol. Neurosurg. Psychiatry 1983, 46:491.
6. Argov Z., Steiner I., Soffer D. The yield of sural nerve biopsy in the evaluation of peripheral neuropathies. Acta Neurol. Scand. 1989, 79:243.
7. Ashworth B., Tait G.B. Trigeminal neuropathy in connective tissue disease. Neurology 1971, 21:609.
8. Bardwick P.A., Zvaifler N.J., Gill G.N., et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore) 1980, 59:311.
9. Barohn R.J. Approach to peripheral neuropathy and neuronopathy. Semin. Neurol. 1998, 18:7.
10. Barohn R.J., Kissel J.T., Warmolts J.R., Mendell J.R. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch. Neurol. 1989, 46:878.
11. Boerkoel C.F., Takashima H., Garcia C.A., et al. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann. Neurol. 2002, 51:190.
12. Bromberg M.B. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve 1991, 14:968.
13. Brown W.F., Strong M.J., Snow R. Methods for estimating numbers of motor units in biceps-brachialis muscles and losses of motor units with aging. Muscle Nerve 1988, 11:423.
14. Busby M., Donaghy M. Predominant arm weakness in acute idiopathic polyneuritis: a distinct regional variant. J. Neurol. 2000, 247:343.
15. Calabresi P.A., Silvestri G., DiMauro S., Griggs R.C. Ekbom's syndrome: lipomas, ataxia, and neuropathy with MERRF. Muscle Nerve 1994, 17:943.
16. Camerlingo M., Nemni R., Ferraro B., et al. Malignancy and sensory neuropathy of unexplained cause: a prospective study of 51 patients. Arch. Neurol. 1998, 55:981.
17. Campbell A.M., Williams E.R. Natural history of Refsum's syndrome in a Gloucestershire family. Br. Med. J. 1967, 3:777.
18. Chalk C.H., Homburger H.A., Dyck P.J. Anti-neutrophil cytoplasmic antibodies in vasculitis peripheral neuropathy. Neurology 1993, 43:1826.
19. Cossoy M.B., Benstead T.J., Sadler R.M. Measurement of serum methylmalonic acid to diagnose cobalamin deficiency in patients with posterior column dysfunction and normal serum vitamin B12 levels. Can. J. Neurol. Sci. 2001, 28(Suppl. 2):S44.
20. Davis M.D., O'Fallon W.M., Rogers R.S., Rooke T.W. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch. Dermatol. 2000, 136:330.
21. Doherty T.J., Brown W.F. The estimated numbers and relative sizes of thenar motor units as selected by multiple point stimulation in young and older adults. Muscle Nerve 1993, 16:355.
22. Doherty T.J., Vandervoort A.A., Brown W.F. Effects of ageing on the motor unit: a brief review. Can. J. Appl. Physiol. 1993, 18:331.
23. Drenth J.P., Michiels J.J. Erythromelalgia and ery-thermalgia: diagnostic differentiation. Int. J. Dermatol. 1994, 33:393.
24. Dressler D., Thompson P.D., Gledhill R.F., Marsden C.D. The syndrome of painful legs and moving toes. Mov. Disord. 1994, 9:13.
25. Duyff R.F., Van den Bosch J., Laman D.M., et al. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J. Neurol. Neurosurg. Psychiatry 2000, 68:750.
26. Dyck P.J., Benstead T.J., Conn D.L., et al. Nonsystemic vasculitic neuropathy. Brain 1987, 110:843. Pt. 4.
27. Dyck P.J., Dyck P.J., Chalk C.H. The 10 P's: a mnemonic helpful in characterization and differential diagnosis of peripheral neuropathy. Neurology 1992, 42:14.
28. Dyck P.J., Dyck P.J., Grant I.A., Fealey R.D. Ten steps in characterizing and diagnosing patients with peripheral neuropathy. Neurology 1996, 47:10.
29. Dyck P.J., Kratz K.M., Karnes J.L., et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993, 43:817.
30. Dyck P.J., Litchy W.J., Lehman K.A., et al. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology 1995, 45:1115.
31. Dyck P.J., Oviatt K.F., Lambert E.H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann. Neurol. 1981, 10:222.
32. Ehle A.L. Lead neuropathy and electrophysiological studies in low level lead exposure: a critical review. Neurotoxicology 1986, 7:203.
33. Ellenberg M. Diabetic neuropathic cachexia. Diabetes 1974, 23:418.
34. Elsehety A., Bertorini T.E. Neurologic and neuro-psychiatric complications of Crohn's disease. South. Med. J. 1997, 90:606.
35. Factors in development of diabetic neuropathy baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes 1988, 37:476.
36. Fagerberg S.-E. Diabetic neuropathy: a clinical and histo-logical study on the significance of vascular affections. Acta Med. Scand. Suppl. 1959, 345:1.
37. Fagius J. Chronic cryptogenic polyneuropathy: the search for a cause. Acta Neurol. Scand. 1983, 67:173.
38. Falco F.J., Hennessey W.J., Goldberg G., Braddom R.L. Standardized nerve conduction studies in the lower limb of the healthy elderly. Am. J. Phys. Med. Rehabil. 1994, 73:168.
39. Farrell D.A., Medsger T.A. Trigeminal neuropathy in progressive systemic sclerosis. Am. J. Med. 1982, 73:57.
40. Fealey R.D. Thermoregulatory sweat test. Clinical Neurophysiology 1996, 396. F. A. Davis, Philadelphia. J.R. Daube (Ed.).
41. Gabriel C.M., Howard R., Kinsella N., et al. Prospective study of the usefulness of sural nerve biopsy. J. Neurol. Neurosurg. Psychiatry 2000, 69:442.
42. Gabriel J.M., Erne B., Bernasconi L., et al. Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy. Acta Neuropathol. (Berl.) 1998, 95:540.
43. Gibbels E., Schaefer H.E., Runne U., et al. Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy: clinical, biochemical, electrophysiological, and morphological evaluation, including electron microscopy of nerve, muscle, and skin biopsies. J. Neurol. 1985, 232:283.
44. Good A.E., Christopher R.P., Koepke G.H., et al. Peripheral neuropathy associated with rheumatoid arthritis: a clinical and electrodiagnostic study of 70 consecutive rheumatoid arthritis patients. Ann. Intern. Med. 1965, 63:87.
45. Gorson K.C., Ropper A.H., Weinberg D.H. Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 1999, 22:758.
46. Gosselin S., Kyle R.A., Dyck P.J. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann. Neurol. 1991, 30:54.
47. Grahmann F., Winterholler M., Neundorfer B. Cryptogenetic polyneuropathies: an out-patient follow-up study. Acta Neurol. Scand. 1991, 84:221.
48. Grant I.A., Hunder G.G., Homburger H.A., Dyck P.J. Peripheral neuropathy associated with sicca complex. Neurology 1997, 48:855.
49. Gruener G., Dyck P.J. Quantitative sensory testing: methodology, applications, and future directions. J. Clin. Neurophysiol. 1994, 11:568.
50. Hanel, P.: Ueber eine Form von nicht beschriebener hereditarer neurotischer Muskelatrophie. In Inaugural Dissertation, Medizinischen Fakultat zu Jena, 1890.
51. Harding A.E. Inherited neuronal atrophy and degeneration predominantly in lower motor neurons. Peripheral Neuropathy 1993, 1051. W. B. Saunders, Philadelphia. 3rd ed. P.J. Dyck, P.K. Thomas, J.W. Griffin (Eds.).
52. Hayward M. Automatic analysis of the electromyogram in healthy subjects of different ages. J. Neurol. Sci. 1977, 33:397.
53. Hellmann D.B., Laing T.J., Petri M., et al. Mononeuritis multiplex: the yield of evaluations for occult rheumatic diseases. Medicine (Baltimore) 1988, 67:145.
54. Herskovitz S., Loh F., Berger A.R., Kucherov M. Erythromelalgia: association with hereditary sensory neuropathy and response to amitriptyline. Neurology 1993, 43(3):621. Pt. 1.
55. Holt I.J., Harding A.E., Petty R.K., Morgan-Hughes J.A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 1990, 46:428.
56. Howard J.E., McGill K.C., Dorfman L.J. Age effects on properties of motor unit action potentials: ADEMG analysis. Ann. Neurol. 1988, 24:207.
57. Hurko O., Provost T.T. Neurology and the skin. J. Neurol. Neurosurg. Psychiatry 1999, 66:417.
58. Itin P.H., Winkelmann R.K. Cutaneous manifestations in patients with essential thrombocythemia. J. Am. Acad. Dermatol. 1991, 24:59.
59. Jann S., Beretta S., Bramerio M., Defanti C.A. Prospective follow-up study of chronic polyneuropathy of undetermined cause. Muscle Nerve 2001, 24:1197.
60. Jenkins R.B. Reynolds, Aldrich or Mees? A consideration of transverse striate leGBRonychia. Am. J. Med. Sci. 1963, 246:707.
61. Kaku D.A., England J.D., Sumner A.J. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994, 117:941. Pt. 5.
62. Kaplan J.G., Pack D., Horoupian D., et al. Distal axonopathy associated with chronic gluten enteropathy: a treatable disorder. Neurology 1988, 38:642.
63. Kelly J.J., Adelman L.S., Berkman E., Bhan I. Polyneuropathies associated with IgM monoclonal gammopathies. Arch. Neurol. 1988, 45:1355.
64. Kissel J.T., Slivka A.P., Warmolts J.R., Mendell J.R. The clinical spectrum of necrotizing angiopathy of the peripheral nervous system. Ann. Neurol. 1985, 18:251.
65. Kovach M.J., Campbell K.C., Herman K., et al. Anticipation in a unique family with Charcot-Marie-Tooth syndrome and deafness: delineation of the clinical features and review of the literature. Am. J. Med. Genet. 2002, 108:295.
66. Kurzrock R., Cohen P.R. Erythromelalgia and myeloproliferative disorders. Arch. Intern. Med. 1989, 149:105.
67. Lagerkvist B.J., Zetterlund B. Assessment of exposure to arsenic among smelter workers: a five-year follow-up. Am. J. Ind. Med. 1994, 25:477.
68. Lander C.M., Eadie M.J., Tyrer J.H. Hereditary motor peripheral neuropathy predominantly affecting the arms. J. Neurol. Sci. 1976, 28:389.
69. Layzer R.B. Hot feet: erythromelalgia and related disorders. J. Child. Neurol. 2001, 16:199.
70. Lecky B.R., Hughes R.A., Murray N.M. Trigeminal sensory neuropathy: a study of 22 cases. Brain 1987, 110:1463. Pt. 6.
71. Lee M.J., Nelson I., Houlden H., et al. Six novel con-nexin32 (GJB1) mutations in X-linked Charcot-Marie-Tooth disease. J. Neurol. Neurosurg. Psychiatry 2002, 73:304.
72. Lee P., Bruni J., SGBRenik S. Neurological manifestations in systemic sclerosis (scleroderma). J. Rheumatol. 1984, 11:480.
73. Leger J.M. Diagnosis of chronic neuropathy. J. Neurol. 1999, 246:156.
74. Lewis R.A., Sumner A.J. The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology 1982, 32:592.
75. Lewis R.A., Sumner A.J., Shy M.E. Electrophysiological features of inherited demyelinating neuropathies: a reappraisal in the era of molecular diagnosis. Muscle Nerve 2000, 23:1472.
76. Lexell J., Downham D.Y. The occurrence of fibre-type grouping in healthy human muscle: a quantitative study of cross-sections of whole vastus lateralis from men between 15 and 83 years. Acta Neuropathol. 1991, 81:377.
77. Lexell J., Taylor C.C., Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J. Neurol. Sci. 1988, 84:275.
78. Lindenbaum J., Healton E.B., Savage D.G., et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N. Engl. J. Med. 1988, 318:1720.
79. Lindenbaum J., Savage D.G., Stabler S.P., Allen R.H. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am. J. Hematol. 1990, 34:99.
80. Lossos A., River Y., Eliakim A., Steiner I. Neurologic aspects of inflammatory bowel disease. Neurology 1995, 45(3):416. Pt. 1.
81. Low P.A., Caskey P.E., Tuck R.R., et al. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann. Neurol. 1983, 14:573.
82. Maisonobe T., Chassande B., Verin M., et al. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients. J. Neurol. Neurosurg. Psychiatry 1996, 61:36.
83. Markesbery W.R., Griggs R.C., Leach R.P., Lapham L.W. Late onset hereditary distal myopathy. Neurology 1974, 24:127.
84. Maryniak O. Severe peripheral neuropathy following gastric bypass surgery for morbid obesity. Can. Med. Assoc. J. 1984, 131:119.
85. McArthur J.C., Stocks E.A., Hauer P., et al. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch. Neurol. 1998, 55:1513.
86. McLeod J.G. Investigation of peripheral neuropathy. J. Neurol. Neurosurg. Psychiatry 1995, 58:274.
87. McLeod J.G., Tuck R.R., Pollard J.D., et al. Chronic polyneuropathy of undetermined cause. J. Neurol. Neurosurg. Psychiatry 1984, 47:530.
88. Menkes D.L. Images in neurology. The cutaneous stigmata of Fabry disease: an X- linked phakomatosis associated with central and peripheral nervous system dysfunction. Arch. Neurol. 1999, 56:487.
89. Michiels J.J., Kate F.J. Erythromelalgia in thrombocythemia of various myeloproliferative disorders. Am. J. Hematol. 1992, 39:131.
90. Milhorat A.T., Wolff H.G. Studies in diseases of muscle: XIII. Progressive muscular dystrophy of atrophic distal type: report on a family: report of autopsy. Arch. Neurol. Psychiatry 1943, 49:655.
91. Misu K., Yoshihara T., Shikama Y., et al. An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J. Neurol. Neurosurg. Psychiatry 2000, 69:806.
92. Mitchell S.W. On a rare vaso-motor neurosis of the extremities, and on the maladies with which it may be confounded. Am. J. Med. Sci. 1878, 76:12.
93. Miyoshi K., Kawai H., Iwasa M., et al. Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy: seventeen cases in eight families including an autopsied case. Brain 1986, 109:31. Pt. 1.
94. Moder K.G. Use and interpretation of rheumatologic tests: a guide for clinicians. Mayo Clin. Proc. 1996, 71:391.
95. Montagna P., Cirignotta F., Sacquegna T., et al. quot;Painful legs and moving toes" associated with polyneuropathy. J. Neurol. Neurosurg. Psychiatry 1983, 46:399.
96. Mouton P., Tardieu S., Gouider R., et al. Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology 1999, 52:1440.
97. Nathan P.W. Painful legs and moving toes: evidence on the site of the lesion. J. Neurol. Neurosurg. Psychiatry 1978, 41:934.
98. Nobile-Orazio E., Manfredini E., Carpo M., et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann. Neurol. 1994, 36:416.
99. Nonaka I., Sunohara N., Ishiura S., Satoyoshi E. Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation. J. Neurol. Sci. 1981, 51:141.
100. Notermans N.C. Monoclonal gammopathy and neuropathy. Curr. Opin. Neurol. 1996, 9:334.
101. Notermans N.C., Wokke J.H., Lokhorst H.M., et al. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: a prospective study of the prognostic value of clinical and laboratory abnormalities. Brain 1994, 117:1385. Pt. 6.
102. Novella S.P., Inzucchi S.E., Goldstein J.M. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001, 24:1229.
103. Ochoa J., Torebjork E. Sensations evoked by intra-neural microstimulation of C nociceptor fibres in human skin nerves. J. Physiol. (Lond.) 1989, 415:583.
104. Pareyson D., Taroni F., Botti S., et al. Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation. Neurology 2000, 54:1696.
105. Perry J.R., Bril V. Complications of sural nerve biopsy in diabetic versus non-diabetic patients. Can. J. Neurol. Sci. 1994, 21:34.
106. Peyronnard J.M., Charron L., Beaudet F., Couture F. Vasculitic neuropathy in rheumatoid disease and Sjogren syndrome. Neurology 1982, 32:839.
107. Pfeifer M.A., Cook D., Brodsky J., et al. Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes 1982, 31(4):339. Pt. 1.
108. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 [author's transl.]. Diabetes Metab. 1977, 3:97.
109. Pitagoras de Mattos J., Oliveira M., Andre C. Painful legs and moving toes associated with neuropathy in HIV-infected patients. Mov. Disord. 1999, 14:1053.
110. Pittock S.J., Payne T.A., Harper C.M. Reversible myelopathy in a 34-year-old man with vitamin B12 deficiency. Mayo Clin. Proc. 2002, 77:291.
111. Pollock M., NGBRada H., Frith R.W., et al. Peripheral neuropathy in Tangier disease. Brain 1983, 106:911. Pt. 4.
112. Porter M.M., Vandervoort A.A., Lexell J. Aging of human muscle: structure, function and adaptability. Scand. J. Med. Sci. Sports 1995, 5:129.
113. Quecedo E., Sanmartin O., Febrer M.I., et al. Mees' lines: a clue for the diagnosis of arsenic poisoning. Arch. Dermatol 1996, 132:349.
114. Quinlan C.D., Martin E.A. Refsum's syndrome: report of three cases. J. Neurol. Neurosurg. Psychiatry 1970, 33:817.
115. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991, 41:617.
116. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 1998, 21(Suppl. 1):S5.
117. Ridley A. The neuropathy of acute intermittent porphyria. Q. J. Med. 1969, 38:307.
118. Ridley A. Porphyric neuropathy. Peripheral Neuropathy 1984, 1704. W. B. Saunders, Philadelphia. 2nd ed. P.J. Dyck, P.K. Thomas, E.H. Lambert, R.P. Bunge (Eds.).
119. Rivner M.H., Swift T.R., Crout B.O., Rhodes K.P. Toward more rational nerve conduction interpretations: the effect of height. Muscle Nerve 1990, 13:232.
120. Rivner M.H., Swift T.R., Malik K. Influence of age and height on nerve conduction. Muscle Nerve 2001, 24:1134.
121. Rosenberg N.R., Portegies P., de Visser M., Vermeulen M. Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline. J. Neurol. Neurosurg. Psychiatry 2001, 71:205.
122. RGBRavina J.G., Block W.D., Jackson C.E. Primary systemic amyloidosis: a review and an experimental genetic and clinical study of 29 cases with particular emphasis on the familial form. Medicine (Baltimore) 1956, 35:239.
123. Said G., Lacroix C., Plante-Bordeneuve V., et al. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain 2002, 125:264. Pt. 2.
124. Said G., Lacroix-Ciaudo C., Fujimura H., et al. The peripheral neuropathy of necrotizing arteritis: a clinico-pathological study. Ann. Neurol. 1988, 23:461.
125. Servidei S., Capon F., Spinazzola A., et al. A distinctive autosomal dominant vacuolar neuromyopathy linked to 19p13. Neurology 1999, 53:830.
126. Simovic D., Gorson K.C., Ropper A.H. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy. Acta Neurol. Scand. 1998, 97:194.
127. Singleton J.R., Smith A.G., Bromberg M.B. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 2001, 24:1225.
128. Skjeldal O.H., Stokke O., Refsum S., et al. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation. J. Neurol. Sci. 1987, 77:87.
129. Spillane J.D., Nathan P.W., Kelly R.E., Marsden C.D. Painful legs and moving toes. Brain 1971, 94:541.
130. Stalberg E., Fawcett P.R. Macro EMG in healthy subjects of different ages. J. Neurol. Neurosurg. Psychiatry 1982, 45:870.
131. Stetson D.S., Albers J.W., Silverstein B.A., Wolfe R.A. Effects of age, sex, and anthropometric factors on nerve conduction measures. Muscle Nerve 1992, 15:1095.
132. Suarez G.A., Chalk C.H., Russell J.W., et al. Diagnostic accuracy and certainty from sequential evaluations in peripheral neuropathy. Neurology 2001, 57:1118.
133. Suarez G.A., Kelly J.J. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Neurology 1993, 43:1304.
134. Thomas P.K., Claus D., Jaspert A., et al. Focal upper limb demyelinating neuropathy. Brain 1996, 119:765. Pt. 3.
135. Timmerman V., Raeymaekers P., Nelis E., et al. Linkage analysis of distal hereditary motor neuropathy type II (distal HMN II) in a single pedigree. J. Neurol. Sci. 1992, 109:41.
136. Tomlinson B.E., Walton J.N., Rebeiz J.J. The effects of ageing and of cachexia upon skeletal muscle: a histopathological study. J. Neurol. Sci. 1969, 9:321.
137. Tyson J., Malcolm S., Thomas P.K., Harding A.E. Deletions of chromosome 17p11.2 in multifocal neuropathies. Ann. Neurol. 1996, 39:180.
138. Udd B., Griggs R. Distal myopathies. Curr. Opin. Neurol. 2001, 14:561.
139. Udd B., Partanen J., Halonen P., et al. Tibial muscular dystrophy: late adult-onset distal myopathy in 66 Finnish patients. Arch. Neurol. 1993, 50:604.
140. Vendrell J., Nubiola A., Goday A., et al. Erythromelalgia associated with acute diabetic neuropathy: an unusual condition. Diabetes Res. 1988, 7:149.
141. Verhagen W.I., Gabreels-Festen A.A., vanWensen P.J, et al. Hereditary neuropathy with liability to pressure palsies: a clinical, electroneurophysiological and morphological study. J. Neurol. Sci. 1993, 116:176.
142. Verhagen W.I., Horstink M.W., Notermans S.L. Painful arm and moving fingers. J. Neurol. Neurosurg. Psychiatry 1985, 48:384.
143. Vicart P., Caron A., Guicheney P., et al. A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat. Genet. 1998, 20:92.
144. Wallace M.R., Conneally P.M., Benson M.D. A DNA test for Indiana/Swiss hereditary amyloidosis (FAP II). Am. J. Hum. Genet. 1988, 43:182.
145. Welander L. Myopathia distalis tarda hereditaria. Acta Med. Scand. 1951, 141:1.
146. Wolfe G.I., Baker N.S., Amato A.A, et al. Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch. Neurol. 1999, 56:540.
147. Wright A., Dyck P.J. Hereditary sensory neuropathy with sensorineural deafness and early-onset dementia. Neurology 1995, 45(3):560. Pt. 1.
148. Wulff C.H. Painful legs and moving toes: a report of 3 cases with neurophysiological studies. Acta Neurol. Scand. 1982, 66:283.